One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study.
Sofikerim
Mustafa
M
Gülmez
Ibrahim
I
Karacagil
Mustafa
M
D000890:Anti-Infective Agents / Q000008:administration & dosage*; D002939:Ciprofloxacin / Q000008:administration & dosage*; D006801:Humans; D009403:Nephrostomy, Percutaneous / Q000009:adverse effects*; D011300:Preoperative Care; D012680:Sensitivity and Specificity; D018805:Sepsis / Q000382:microbiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000382:microbiology / Q000517:prevention & control*
D000890:Anti-Infective Agents; D002939:Ciprofloxacin